Total Payments
$921.57
2022 Payments
$345.16
Companies
17
Transactions
72
Medicare Patients
1,959
Medicare Billing
$112,492
Payment Breakdown by Category
Food & Beverage$900.57 (97.7%)
Education$21.00 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $900.57 | 71 | 97.7% |
| Education | $21.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neos Therapeutics, LP | $166.65 | 15 | $0 (2022) |
| Daiichi Sankyo Inc. | $153.26 | 13 | $0 (2022) |
| GlaxoSmithKline, LLC. | $86.57 | 6 | $0 (2022) |
| Novo Nordisk Inc | $77.21 | 6 | $0 (2022) |
| ABBVIE INC. | $77.08 | 6 | $0 (2022) |
| Lilly USA, LLC | $65.74 | 5 | $0 (2021) |
| Lundbeck LLC | $55.40 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $46.44 | 4 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.64 | 3 | $0 (2022) |
| ARBOR PHARMACEUTICALS, INC. | $31.53 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $345.16 | 27 | Neos Therapeutics, LP ($119.35) |
| 2021 | $576.41 | 45 | Daiichi Sankyo Inc. ($114.82) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: VACCINES | ||||||
| 09/11/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: VACCINES | ||||||
| 06/29/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: ADHD | ||||||
| 06/22/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: ADHD | ||||||
| 06/16/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | Cash or cash equivalent | $7.35 | General |
| Category: ADHD | ||||||
| 06/09/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: VACCINES | ||||||
| 06/01/2022 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Neurology | ||||||
| 05/18/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $11.40 | General |
| Category: ADHD | ||||||
| 05/11/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/03/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $11.09 | General |
| Category: ADHD | ||||||
| 04/22/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $12.64 | General |
| Category: ADHD | ||||||
| 04/14/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $12.02 | General |
| Category: ADHD | ||||||
| 04/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.12 | General |
| 04/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2022 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: PSYCHIATRY | ||||||
| 03/29/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $7.34 | General |
| Category: ADHD | ||||||
| 03/23/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: VACCINES | ||||||
| 03/18/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/15/2022 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROLOGY | ||||||
| 03/08/2022 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/08/2022 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $12.31 | General |
| Category: ADHD | ||||||
| 02/23/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/11/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 432 | 570 | $102,841 | $22,309 |
| 2021 | 15 | 777 | 1,090 | $188,354 | $51,126 |
| 2020 | 15 | 750 | 1,002 | $164,705 | $39,057 |
Total Patients
1,959
Total Services
2,662
Medicare Billing
$112,492
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 224 | $55,328 | $10,622 | 19.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $18,659 | $5,859 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 63 | $22,869 | $4,882 | 21.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 124 | 166 | $2,490 | $494.01 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 45 | $2,655 | $308.73 | 11.6% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 11 | 11 | $784.00 | $112.30 | 14.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 12 | 14 | $56.00 | $31.38 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 344 | $84,968 | $19,289 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 81 | 81 | $32,157 | $10,266 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 81 | $29,403 | $7,244 | 24.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 54 | 54 | $3,996 | $3,524 | 88.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 19 | 19 | $11,020 | $3,037 | 27.6% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 18 | 18 | $2,628 | $2,255 | 85.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 13 | 25 | $5,775 | $1,292 | 22.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 63 | 64 | $2,240 | $1,249 | 55.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $4,004 | $803.92 | 20.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 153 | 252 | $3,780 | $756.00 | 20.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 69 | 73 | $4,307 | $487.23 | 11.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 19 | 19 | $1,026 | $371.36 | 36.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,950 | $339.55 | 17.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2021 | 12 | 13 | $1,008 | $159.37 | 15.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 21 | 23 | $92.00 | $51.75 | 56.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 160 | 308 | $75,804 | $12,837 | 16.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 65 | 65 | $25,753 | $7,320 | 28.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 88 | $31,944 | $5,466 | 17.1% |
About Molly Lawrence
Molly Lawrence is a Family healthcare provider based in Cedar Knolls, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518997063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molly Lawrence has received a total of $921.57 in payments from pharmaceutical and medical device companies, with $345.16 received in 2022. These payments were reported across 72 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($900.57).
As a Medicare-enrolled provider, Lawrence has provided services to 1,959 Medicare beneficiaries, totaling 2,662 services with total Medicare billing of $112,492. Data is available for 3 years (2020–2022), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cedar Knolls, NJ
- Active Since 07/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1518997063
Products in Payments
- Adzenys XR-ODT (Drug) $168.12
- INJECTAFER (Drug) $153.26
- SHINGRIX (Biological) $59.66
- BRINTELLIX (Drug) $55.40
- TRULICITY (Drug) $53.44
- Ozempic (Drug) $52.80
- VRAYLAR (Drug) $48.10
- FARXIGA (Drug) $46.44
- VYVANSE (Drug) $39.64
- Livalo (Drug) $27.76
- Kloxxado (Drug) $21.00
- Edarbi (Drug) $16.53
- APLENZIN (Drug) $16.46
- AUVI-Q (Drug) $15.00
- Horizant (Drug) $15.00
- UBRELVY (Drug) $14.92
- TRELEGY ELLIPTA (Drug) $14.62
- SUNOSI (Drug) $14.33
- QULIPTA (Drug) $14.06
- QELBREE (Drug) $13.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cedar Knolls
Mrs. Natia Rufolo, Apn, APN
Family — Payments: $3,079
Family $3,079
Nerlande Joasil, Apn, APN
Family — Payments: $2,856
Family $2,856
Jillian Nati, Fnp, FNP
Family — Payments: $1,840
Family $1,840
Alexa Dendulk, Fnp-C, Apn, FNP-C, APN
Family — Payments: $1,278
Family $1,278
Nathalie Hughes
Family — Payments: $906.82
Family $906.82
Kaltrina Osmani
Family — Payments: $167.05
Family $167.05